The main detected compound (naringenin) in the LLEs was docked molecularly with acetylcholinesterase and butyrylcholinesterase as indicators of Alzheimer’s disease development. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.